Search Results - Caicun Zhou
- Showing 1 - 20 results of 144
- Go to Next Page
-
1
-
2
Lung cancer in never smokers—the East Asian experience by Fei Zhou, Caicun Zhou
Published 2018Revisão -
3
-
4
Role of IL-2 in cancer immunotherapy by Tao Jiang, Caicun Zhou, Shengxiang Ren
Published 2016Revisão -
5
The cutting-edge progress of immune-checkpoint blockade in lung cancer by Fei Zhou, Meng Qiao, Caicun Zhou
Published 2020Revisão -
6
-
7
Non‐small cell lung cancer in China by Peixin Chen, Yunhuan Liu, Yaokai Wen, Caicun Zhou
Published 2022Revisão -
8
-
9
-
10
-
11
-
12
-
13
-
14
Single‐cell transcriptomics reveal metastatic <i>CLDN4</i>+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cance... by Xiaoshen Zhang, Xuanhe Wang, Yaokai Wen, Chen Shen, Caicun Zhou, Fengying Wu
Published 2024Artigo -
15
PD-L1 Expression in Lung Cancer by Hui Yu, Theresa A. Boyle, Caicun Zhou, David L. Rimm, Fred R. Hirsch
Published 2016Revisão -
16
TIM-3, a promising target for cancer immunotherapy by Yayi He, Jie Cao, Chao Zhao, Xuefei Li, Caicun Zhou, Fred R. Hirsch
Published 2018Revisão -
17
-
18
-
19
-
20
Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs by Qinghua Xu, Fei Zhou, Hui Liu, Tao Jiang, Xuefei Li, Yaping Xu, Caicun Zhou
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Cancer research
Biology
Chemotherapy
Epidermal growth factor receptor
Immunotherapy
Gene
Biochemistry
Genetics
Confidence interval
Adenocarcinoma
Immunology
Pathology
Gastroenterology
Gefitinib
Erlotinib
Hazard ratio
Clinical endpoint
Immune system
Cisplatin
Randomized controlled trial
Surgery
Clinical trial
Mutation
Progression-free survival
Adverse effect